Free Trial
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

Chemours logo
$20.86 +0.37 (+1.78%)
Closing price 03:59 PM Eastern
Extended Trading
$20.86 0.00 (0.00%)
As of 06:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Chemours Stock (NYSE:CC)

Advanced

Key Stats

Today's Range
$20.35
$21.05
50-Day Range
$20.46
$27.93
52-Week Range
$10.14
$28.67
Volume
1.18 million shs
Average Volume
3.21 million shs
Market Capitalization
$3.14 billion
P/E Ratio
N/A
Dividend Yield
1.68%
Price Target
$24.60
Consensus Rating
Hold

Company Overview

Chemours Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
64th Percentile Overall Score

CC MarketRank™: 

Chemours scored higher than 64% of companies evaluated by MarketBeat, and ranked 93rd out of 180 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemours has received a consensus rating of Hold. The company's average rating score is 2.42, and is based on no strong buy ratings, 6 buy ratings, 5 hold ratings, and 1 sell rating.

  • Upside Potential

    Chemours has a consensus price target of $24.60, representing about 17.9% upside from its current price of $20.87.

  • Amount of Analyst Coverage

    Chemours has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Chemours' stock forecast and price target.
  • Earnings Growth

    Earnings for Chemours are expected to grow by 78.74% in the coming year, from $1.27 to $2.27 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemours is -7.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemours is -7.90, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Chemours has a P/B Ratio of 12.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemours' valuation and earnings.
  • Percentage of Shares Shorted

    6.37% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 2.48, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemours has recently increased by 12.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Chemours pays a meaningful dividend of 1.62%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemours does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Chemours will have a dividend payout ratio of 15.42% next year. This indicates that Chemours will be able to sustain or increase its dividend.

  • Read more about Chemours' dividend.
  • News Sentiment

    Chemours has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Basic Materials companies.
  • Search Interest

    Only 4 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemours insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.85% of the stock of Chemours is held by insiders.

  • Percentage Held by Institutions

    76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemours' insider trading history.
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CC Stock News Headlines

Important SpaceX PREDICTION
The biggest IPO in stock market history could go live as soon as June 12th — but trading legend Jon Najarian says investors are about to miss the real opportunity. A little-known FCC filing Elon quietly submitted earlier this year has caught Morgan Stanley's attention — and they estimate it could be worth $40 trillion. That's larger than Tesla, xAI, Starlink, X, Neuralink, and SpaceX combined.tc pixel
See More Headlines

CC Stock Analysis - Frequently Asked Questions

Chemours' stock was trading at $11.76 at the start of the year. Since then, CC stock has increased by 77.4% and is now trading at $20.8650.

The Chemours Company (NYSE:CC) posted its quarterly earnings data on Tuesday, May, 5th. The specialty chemicals company reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.05) by $0.10. The business's revenue for the quarter was up 1.0% on a year-over-year basis.
Read the conference call transcript
.

Chemours' top institutional shareholders include Dimensional Fund Advisors LP (1.49%), Bank of New York Mellon Corp (1.07%), Bank of America Corp DE (0.88%) and Principal Financial Group Inc. (0.49%). Insiders that own company stock include Mark Newman, Denise Dignam, Damian Gumpel, Shane Hostetter, Matthew S Abbott, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends
.

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Record date for 3/13 Dividend
2/27/2026
Ex-Dividend for 3/13 Dividend
2/27/2026
Dividend Payable
3/13/2026
Last Earnings
5/05/2026
Ex-Dividend for 6/16 Dividend
5/15/2026
Record date for 6/16 Dividend
5/17/2026
Today
6/08/2026
Dividend Payable
6/16/2026
Next Earnings (Estimated)
8/04/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
CHEM - DIVERSIFD
Sub-Industry
Chemicals
Current Symbol
NYSE:CC
CIK
1627223
Fax
N/A
Employees
5,700
Year Founded
2015

Price Target and Rating

High Price Target
$30.00
Low Price Target
$17.00
Potential Upside/Downside
+17.9%
Consensus Rating
Hold
Rating Score (0-4)
2.42
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
16.43
P/E Growth
N/A
Net Income
-$386 million
Net Margins
-6.82%
Pretax Margin
-5.14%
Return on Equity
52.49%
Return on Assets
1.78%

Debt

Debt-to-Equity Ratio
18.98
Current Ratio
1.82
Quick Ratio
0.87

Sales & Book Value

Annual Sales
$5.82 billion
Price / Sales
0.54
Cash Flow
$3.35 per share
Price / Cash Flow
6.22
Book Value
$1.67 per share
Price / Book
12.49

Miscellaneous

Outstanding Shares
150,378,000
Free Float
149,100,000
Market Cap
$3.14 billion
Optionable
Optionable
Beta
1.39

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NYSE:CC) was last updated on 6/8/2026 by MarketBeat.com Staff.
From Our Partners